Technavio has been monitoring the exosome diagnostics and therapeutics market and it is poised to grow by $ 419.37 mn during 2022-2026, progressing at a CAGR of 23.49% during the forecast period. Our report on the exosome diagnostics and therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing research on exosome therapeutics and increasing demand for effective drugs for chronic diseases. In addition, increasing research on exosome therapeutics is anticipated to boost the growth of the market as well.
The exosome diagnostics and therapeutics market analysis includes the end-user segment and geographic landscape.
Technavio's exosome diagnostics and therapeutics market is segmented as below:
By End-user
- Research and academic institutes
- Pharmaceutical and biotechnology companies
- Commercial
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the increasing focus on early detection of cancer as one of the prime reasons driving the exosome diagnostics and therapeutics market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on exosome diagnostics and therapeutics market covers the following areas:
- Exosome diagnostics and therapeutics market sizing
- Exosome diagnostics and therapeutics market forecast
- Exosome diagnostics and therapeutics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading exosome diagnostics and therapeutics market vendors that include Aethlon Medical Inc., Bio Techne Corp., Evox Therapeutics Ltd., Hologic Inc., JSR Life Sciences LLC, Lonza Group Ltd., Nanosomix Inc., NX PharmaGen Inc., QIAGEN NV, and System Biosciences LLC. Also, the exosome diagnostics and therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
- Executive Summary
- Market Landscape
- Market ecosystem
- Value chain analysis
- Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021 - 2026
- Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market Segmentation by End-user
- Market segments
- Comparison by End-user
- Research and academic institutes - Market size and forecast 2021-2026
- Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
- Commercial - Market size and forecast 2021-2026
- Market opportunity by End-user
- Customer landscape
- Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2021-2026
- Europe - Market size and forecast 2021-2026
- Asia - Market size and forecast 2021-2026
- ROW - Market size and forecast 2021-2026
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
- Vendor Landscape
- Overview
- Landscape disruption
- Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Aethlon Medical Inc.
- Bio Techne Corp.
- Evox Therapeutics Ltd.
- Hologic Inc.
- JSR Life Sciences LLC
- Lonza Group Ltd.
- Nanosomix Inc.
- NX PharmaGen Inc.
- QIAGEN NV
- System Biosciences LLC.
- Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Exhibits
- 1: Key Finding 1
- 2: Key Finding 2
- 3: Key Finding 3
- 4: Key Finding 5
- 5: Key Finding 6
- 6: Key Finding 7
- 7: Key Finding 8
- 8: Parent market
- 9: Market characteristics
- 10: Offerings of vendors included in the market definition
- 11: Market segments
- 12: Global - Market size and forecast 2021 - 2026 ($ million)
- 13: Global market: Year-over-year growth 2021 - 2026 (%)
- 14: Five forces analysis 2021 & 2026
- 15: Bargaining power of buyers
- 16: Bargaining power of suppliers
- 17: Threat of new entrants
- 18: Threat of substitutes
- 19: Threat of rivalry
- 20: Market condition - Five forces 2021
- 21: End-user - Market share 2021-2026 (%)
- 22: Comparison by End-user
- 23: Research and academic institutes - Market size and forecast 2021-2026 ($ million)
- 24: Research and academic institutes - Year-over-year growth 2021-2026 (%)
- 25: Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
- 26: Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
- 27: Commercial - Market size and forecast 2021-2026 ($ million)
- 28: Commercial - Year-over-year growth 2021-2026 (%)
- 29: Market opportunity by End-user
- 30: Customer landscape
- 31: Market share By Geographical Landscape 2021-2026 (%)
- 32: Geographic comparison
- 33: North America - Market size and forecast 2021-2026 ($ million)
- 34: North America - Year-over-year growth 2021-2026 (%)
- 35: Europe - Market size and forecast 2021-2026 ($ million)
- 36: Europe - Year-over-year growth 2021-2026 (%)
- 37: Asia - Market size and forecast 2021-2026 ($ million)
- 38: Asia - Year-over-year growth 2021-2026 (%)
- 39: ROW - Market size and forecast 2021-2026 ($ million)
- 40: ROW - Year-over-year growth 2021-2026 (%)
- 41: Key leading countries
- 42: Market opportunity By Geographical Landscape ($ million)
- 43: Impact of drivers and challenges
- 44: Vendor landscape
- 45: Landscape disruption
- 46: Industry risks
- 47: Vendors covered
- 48: Market positioning of vendors
- 49: Aethlon Medical Inc. - Overview
- 50: Aethlon Medical Inc. - Business segments
- 51: Aethlon Medical Inc. - Key offerings
- 52: Aethlon Medical Inc. - Key customers
- 53: Aethlon Medical Inc. - Segment focus
- 54: Bio Techne Corp. - Overview
- 55: Bio Techne Corp. - Business segments
- 56: Bio Techne Corp. - Key offerings
- 57: Bio Techne Corp. - Key customers
- 58: Bio Techne Corp. - Segment focus
- 59: Evox Therapeutics Ltd. - Overview
- 60: Evox Therapeutics Ltd. - Product and service
- 61: Evox Therapeutics Ltd. - Key offerings
- 62: Evox Therapeutics Ltd. - Key customers
- 63: Evox Therapeutics Ltd. - Segment focus
- 64: Hologic Inc. - Overview
- 65: Hologic Inc. - Business segments
- 66: Hologic Inc. - Key offerings
- 67: Hologic Inc. - Key customers
- 68: Hologic Inc. - Segment focus
- 69: JSR Life Sciences LLC - Overview
- 70: JSR Life Sciences LLC - Product and service
- 71: JSR Life Sciences LLC - Key offerings
- 72: JSR Life Sciences LLC - Key customers
- 73: JSR Life Sciences LLC - Segment focus
- 74: Lonza Group Ltd. - Overview
- 75: Lonza Group Ltd. - Business segments
- 76: Lonza Group Ltd. - Key offerings
- 77: Lonza Group Ltd. - Key customers
- 78: Lonza Group Ltd. - Segment focus
- 79: Nanosomix Inc. - Overview
- 80: Nanosomix Inc. - Product and service
- 81: Nanosomix Inc. - Key offerings
- 82: Nanosomix Inc. - Key customers
- 83: Nanosomix Inc. - Segment focus
- 84: NX PharmaGen Inc. - Overview
- 85: NX PharmaGen Inc. - Product and service
- 86: NX PharmaGen Inc. - Key offerings
- 87: NX PharmaGen Inc. - Key customers
- 88: NX PharmaGen Inc. - Segment focus
- 89: QIAGEN NV - Overview
- 90: QIAGEN NV - Business segments
- 91: QIAGEN NV - Key offerings
- 92: QIAGEN NV - Key customers
- 93: QIAGEN NV - Segment focus
- 94: System Biosciences LLC. - Overview
- 95: System Biosciences LLC. - Product and service
- 96: System Biosciences LLC. - Key offerings
- 97: System Biosciences LLC. - Key customers
- 98: System Biosciences LLC. - Segment focus
- 99: Currency conversion rates for US$
- 100: Research Methodology
- 101: Validation techniques employed for market sizing
- 102: Information sources
- 103: List of abbreviations
